SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004166
Filing Date
2018-05-07
Accepted
2018-05-07 17:18:40
Documents
60
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20180331x10q.htm 10-Q 1932463
2 EX-31.1 xncr-20180331ex3110416ff.htm EX-31.1 19394
3 EX-31.2 xncr-20180331ex312671520.htm EX-31.2 19378
4 EX-32.1 xncr-20180331ex3216cbcc9.htm EX-32.1 10585
  Complete submission text file 0001558370-18-004166.txt   8901951

Data Files

Seq Description Document Type Size
5 EX-101.INS xncr-20180331.xml EX-101.INS 2359532
6 EX-101.SCH xncr-20180331.xsd EX-101.SCH 40026
7 EX-101.CAL xncr-20180331_cal.xml EX-101.CAL 41955
8 EX-101.DEF xncr-20180331_def.xml EX-101.DEF 222183
9 EX-101.LAB xncr-20180331_lab.xml EX-101.LAB 406217
10 EX-101.PRE xncr-20180331_pre.xml EX-101.PRE 381797
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 18812216
SIC: 2834 Pharmaceutical Preparations